FDG-PET for response assessment of malignant lymphoma

研究成果: ジャーナルへの寄稿総説査読

抄録

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is a promising functional imaging test for patients with malignant lymphoma (ML) , and has gained wide usage during the last decade. In 2007, an International Harmonization Project (IHP) proposed revised response criteria for evaluating therapy responses in ML and consensus recommendations of FDG-PET for this purpose. The relevance of the response criteria and consensus recommendations should be validated in prospective clinical trials. Clinicians should utilize them cautiously in clinical practice because clinical data on decision making depending on these guidelines are still limited.

本文言語英語
ページ(範囲)418-424
ページ数7
ジャーナルJapanese Journal of Clinical Radiology
52
3
出版ステータス出版済み - 2007
外部発表はい

All Science Journal Classification (ASJC) codes

  • 放射線学、核医学およびイメージング

フィンガープリント

「FDG-PET for response assessment of malignant lymphoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル